Complex Discovery

OCTOBER 19, 2024

Editor’s Note: Artificial intelligence (AI) is transforming the pharmaceutical industry, offering unprecedented opportunities to accelerate drug discovery, streamline clinical trials, and fortify intellectual property (IP) strategies.

Pharmaceuticals 111

Pharmaceuticals Discovery Government and Public Sector Chain Of Custody 111

IP Watchdog

JULY 13, 2023

On July 7, 2023, the district court invalidated the patent for lack of written description despite rejecting an enablement defense based upon the same evidence.

Technology 52

Technology Pharmaceuticals Construction Evidence 52

IP Watchdog

AUGUST 26, 2021

The CAFC found that the jury’s verdict with respect to written description was not supported by substantial evidence. The patent generally covers cancer immunotherapy technology. The case relates to U.S. 7,446,190, owned by Sloan Kettering, which is titled “Nucleic Acids Encoding Chimeric T Cell Receptors.” Juno sued Kite Pharma, Inc.

Trial Brief 122

Trial Brief Evidence Technology Pharmaceuticals 122

Complex Discovery

APRIL 18, 2025

Editor’s Note: Blockchain is no longer a niche technology tied solely to cryptocurrencyit is now a cornerstone of innovation across industries critical to cybersecurity, information governance, and eDiscovery. Healthcare is another field where blockchain is making significant inroads.

Government and Public Sector 52

Government and Public Sector Chain Of Custody Digital Evidence Evidence 52

CaseFox

NOVEMBER 27, 2023

From the traditional focus on environmental and occupational hazards to the exploration of new frontiers in pharmaceuticals and consumer products. Cases related to pharmaceutical drugs, consumer products, and emerging contaminants in drinking water are gaining prominence.

Litigation 52

Litigation Pharmaceuticals Expert Testimony Evidence 52

Complex Discovery

NOVEMBER 3, 2024

The podcast provides an automated yet insightful look at AI’s evolving impact, enriching the way information is consumed and discussed within the legal technology field. As October 2024 concluded, it continues to be evident that the eDiscovery, cybersecurity, and information governance sectors are undergoing significant transformations.

Government and Public Sector 69

Government and Public Sector Technology Cross-Examination Energy and Utilities 69

Attorney at Work

MAY 30, 2022

Let’s say you’re a trade secrets lawyer, and the problem that triggers demand for you is that of talent moving from one technology company to another, taking with them proprietary information stored in their brains. It’s time to offer a short bit of categorical evidence that a solution exists, then make your exit. What did you mean?

Pharmaceuticals 246

Pharmaceuticals Manufacturing Evidence Technology 246